More stories

  • in

    India’s wedding season is here, but for many it’s no longer the bigger, the better

    Many millennial couples in India no longer see the appeal of having wedding guest lists with hundreds of people.
    Despite couples trimming the size of their weddings, they’re spending just as much.
    Major spending for venues, food and decorations remain the norm, said one wedding planner.

    Wedding ceremonies are held differently even within India with some couples choosing big religious ceremonies, while others lean toward a more intimate celebration.
    Rvimages | E+ | Getty Images

    Indian weddings are big business. But some of them may not be quite so big this year as they once would have been.
    The celebrations are famously known for being week-long extravagant affairs filled with elaborate religious ceremonies, glamorous outfits, singing and dancing, and of course lots of jewelry. 

    Many couples in India get married from November to February, which is viewed as an auspicious period in Indian culture.
    According to Nikkei Asia, trade body Confederation of All India Traders (CAIT) estimated that 3.2 million weddings would happen during November to December of last year.
    Celebrations in that month would have generated 3.75 trillion rupees ($46 billion) for businesses in the wedding industry, a steep increase from 2.5 trillion rupees in 2019, Nikkei Asia reported based on data from CAIT.
    It’s therefore no surprise that lavish Indian weddings often draw up to 1,000 guests — and that comes with a hefty price tag.
    However, the mindsets of millennials in India have changed, and many are starting to believe that less is more. 

    Couples are moving away from “big, fat” Indian weddings toward intimate celebrations with a slimmer guest list, said Tina Tharwani, co-founder of Mumbai-based wedding planning company Shaadi Squad. 
    They have chosen to give guests a more personalized experience at the event, rather than making it a competition with their peers on who can throw a biggest wedding, Tharwani told CNBC.

    Smita Gupta, founder of Delhi-based wedding planner Wedlock Events, agreed.
    “The success of weddings obviously depends on the guests, but it’s not the number of guests nowadays,” Gupta said. “They are more worried [about] the guest experience.”
    “If you call 600 guests to your wedding, it’s just extra money that you’re paying,” said 29-year old Manika Singh. She is getting married in December 2023 and plans to invite only up to 250 guests for the main celebration, which will be held at the Jim Corbett National Park in Uttarakhand. 
    Renting the venue for two days will set the couple back by 1,500,000 rupees ($18,400), or about 600,000 rupees ($7,400) more than what it was before the pandemic and higher inflation. 

    Feeding people isn’t cheap

    But cutting her guest list came with a caveat. 
    To accommodate her parents’ desire for a big wedding, Singh will also have a lunch reception for 300 guests at the family home a day before.
    “You won’t even know half of the people, they’re just acquaintances of your parents,” she said, adding that this is a common practice that couples often succumb to to pacify their families.
    Despite couples trimming the size of their weddings, they’re spending just as much. Even with a shorter guest list, spending big on the venue, food and decorations remains the norm, Gupta said. 
    Singh agreed, adding that inflation has driven up the cost of food, and rice prices “have gone through the roof.” 

    Rising inflation has caused many soon-to-wed couples to spend a large amount of their budget on food.
    Jupiterimages | The Image Bank | Getty Images

    Although India’s retail inflation dipped from 5.88% in November to 5.72% in December, cereal and milk prices continue to rise, according to Reuters.
    Singh anticipates food being the costliest item at both the lunch reception and wedding celebration in December. 
    That affirmed her decision to scale down the number of guests at her wedding but spend more on her outfit and jewelry instead, which is costing her 700,000 rupees ($8,600) 
    “More people means less luxury at your wedding,” Singh said, “We can splurge on that instead of feeding people.”

    Pricey gold? No problem

    Gold prices hit eight-month highs on Tuesday, with spot gold trading at $1,877 an ounce. 
    But that isn’t stopping soon-to-be married couples from buying gold for their big day, Ramesh Kalyanaraman, executive director at Kalyan Jewellers said. 
    High costs haven’t necessarily deterred people from making big purchases, but they may wait a couple of weeks to see if prices drop, Kalyanaraman said. “It is not a drop” in sales, he said, but “a delay in their purchases.”

    According to the World Gold Council, India’s gold industry contributed 1.3% to the country’s GDP and is dominated by small and medium enterprises.
    Bhawna Jain / Eyeem | Eyeem | Getty Images

    And that was no different during Covid. 
    Kalyanaraman said the ticket size for wedding jewelry was much higher during the pandemic, because people were unable to spend money on entertainment or rent big marriage halls due to government restrictions. 
    “Gold jewelry is not a fashion accessory; it is actually a part of every custom and ritual,” he said. 
    Kalyanaraman said that in some Indian cities, parents start buying gold for their daughters from birth and will continue adding to the collection as they grow older. Many of those pieces are then worn on their wedding day.
    Singh said she has a different stance and won’t be decked out in expensive jewelry. She will purchase only one set of new jewelry, and use another from her engagement ceremony. For the rest of it, she is “just going to wear fake jewelry.”

    WATCH LIVEWATCH IN THE APP More

  • in

    The global health-care collapse

    The imposition of lockdowns during the covid-19 pandemic had one overarching aim: to prevent hospitals from being overwhelmed. Governments hoped to space out infections, buying time to build capacity. In the end, however, much of this extra capacity went unused. England’s seven “Nightingale” hospitals closed having received only a few patients, as did many of America’s field hospitals. A study of Europe’s experience in Health Policy, a journal, found only one example where there were more covid patients than intensive-care beds: in the Italian region of Lombardy on April 3rd 2020. Although there are now stories of overwhelmed Chinese hospitals, as the country confronts a great exit wave, it is too soon to know whether these are isolated examples or represent broader, systematic failure.Outside China, covid weighs less on people’s minds these days. Yet health-care systems in the rich world are closer to collapse than at any point since the disease started to spread. Unlike for unemployment or gdp, there are few comparable, up-to-date figures on health care across countries. So The Economist has trawled statistics produced by countries, regions and even individual hospitals to paint a picture of what is going on. The results suggest patients, doctors and nurses did not escape the worst effects of the pandemic. Instead, the effects seem to have been delayed.Start with Britain, which produces excellent data. The National Health Service (nhs), the country’s state-run provider, is in dire straits. Just before the pandemic, someone with a medical issue requiring urgent but not immediate attention, a category that includes strokes and heart attacks, waited on average 20 minutes for an ambulance. Now they wait longer than an hour and a half (see chart). The number of long “trolley waits”—the time between a decision to admit and a patient arriving at a hospital ward—has jumped. Other countries have less comprehensive statistics, but equally miserable patients. In September Ipsos, a pollster, released a global survey that included a question on health-care quality. In almost all of the 20-odd rich countries, people were less likely than in 2021 to say that the service on offer was “good” or “very good”. In Britain the share saying so fell by five percentage points. In Canada it fell by ten. In Italy by 12.Italian hospitals inundated by covid patients in early 2020 are struggling once again. We analysed data from the Pope John XXIII hospital in Bergamo, the site of some of the harrowing images of people on ventilators nearly three years ago. In the year covid hit Italy, the hospital’s waiting lists rose slightly on some measures. They then fell slightly the next year. But in 2022 they jumped. Someone in the city looking for a non-urgent breast ultrasound may have to wait as long as two years. Officials in Emilia-Romagna, another region hit hard in 2020, have launched a plan to return waiting lists to pre-pandemic levels.Newspapers across the Anglosphere are filled with horror stories. In New South Wales, Australia, some 25% of patients had to wait more than half an hour to be transferred from paramedics to emergency-room staff in the third quarter of 2022, up from 11% two years before. In Canada waiting times have reached an all-time high, with a median delay of half a year between referral and treatment. Even the richest, most competent countries are feeling the strain. In Switzerland there are fewer free intensive-care beds than at most points in the pandemic. Germany is seeing similar problems, with a surge in patients reducing intensive-care capacity (see chart). In Singapore patients waited for about nine hours to be seen at the average polyclinic at the end of 2021. By October 2022 they were waiting for 13.America is doing better than most countries, thanks to the vast amount of money it spends on health care. But it is not doing well. Average hospital-occupancy rates recently exceeded 80% for the first time. Even in the darkest days of the pandemic few states reported paediatric wards under stress (which we define as 90% or more beds being occupied). In early November fully 17 states were in this position, the result of a rise in all sorts of bugs in kids. The collapse in the quality of health care is contributing to an astonishing rise in “excess deaths”—those above what would be expected in a normal year. In many rich-world countries 2022 proved deadlier even than 2021, a year of several big waves of covid. Monthly deaths across Europe are currently about 10% higher than expected. Germany is in the middle of a vast mortality wave: weekly deaths have been more than 10% above normal since September. In early December they were 23% higher. What is going on? Politicians, at both a national and regional level, are taking the blame—and occasionally deserve it. But the forces creating the chaos are common across countries, and are linked to a shared experience of the pandemic. They may also, in the short term at least, be almost impossible for governments to overcome. Across the oecd club of mostly rich countries, health expenditure is now not far short of 10% of gdp, having been below 9% before the pandemic (see chart). Of the 20 countries for which there are data for 2021, 18 spent more per person than ever before. Almost all spent more as a share of gdp than in 2019. Adjusting these figures for ageing populations does not meaningfully change these findings. The problems facing health-care systems are not therefore caused by a lack of cash. Much of the increased spending has gone on programmes to combat covid, including testing and tracing, and buying vaccines. But funding is now rising across systems more broadly. In almost every rich country more people are working in health care than ever before. Total employment in hospitals in 2021 was 9% higher than in the year before the pandemic in the six oecd countries we surveyed. The latest data suggest that in Canada 1.6m people now work in health care, the most ever. In the eu more than 12m people work in “human-health activities”, a record. American hospitals employ 5.3m people, another record. Perhaps the real problem is not staff numbers, but how efficiently they are working. Real output in America’s hospital and ambulatory-health-care sector, which in effect measures the quantity of care provided, is only 3.9% above its pre-pandemic level, whereas output across the economy as a whole is 6.4% higher. In England elective-care activity (ie, surgery planned in advance) is slightly lower than it was before covid hit. In Western Australia the share of delayed elective surgeries jumped from 11% to 24% in the two years to November. Hospitals are, in other words, doing less with more. Although falling productivity is an economywide phenomenon, health care currently suffers from additional pressures. A recent paper by Diane Coyle of Cambridge University and colleagues considers the effects of dealing with covid in Britain. “Donning and doffing” protocols to replace protective kit and cleaning requirements after dealing with covid patients, which are still in force in many countries today, slow everything down. The segregation of covid from non-covid patients limits bed allocation. Meanwhile, many staff feel wretched after three gruelling years. A report in Mayo Clinic Proceedings, a journal, finds that quantitative measures of “burnout” among American physicians have shot up (see chart). If health-care workers are demotivated, they may do fewer of the things that once kept the show on the road—such as staying late to make sure the patients’ register is in order or helping with the treatment of another medic’s patient. Yet even though productivity has dropped, it has not fallen by enough to fully explain the health-care collapse. This suggests that the true explanation for the breakdown lies on the other side of the coin: in exploding demand. Coming out of lockdowns, people seem to require more medical help than ever before. Some of this is to do with immunity. People went two years without being exposed to various bugs. Since then, endemic pathogens such as respiratory syncytial virus have bloomed. Everyone you know has—or has recently had—the flu. But the pandemic also bottled up other conditions, which are only now being diagnosed. In 2020-21 many people delayed seeking treatment for fear of catching covid, or because hospitals were shut to non-covid conditions. In Italy cancer diagnoses fell by 39% in 2020 compared with 2018-19. A study of American patients noted a particular reduction in diagnoses was recorded, over a similar period, in cancers normally found during a screening or routine examination. In England, the nhs waiting list has grown by more than 60% since the pandemic was declared. Many of the people on the list, and on similar ones in other countries, are likely to be sicker, and thus to take up more resources than if they had received care in 2020. A recent paper published in Lancet Public Health, another journal, estimates that over the next two decades deaths from colorectal cancer could be nearly 10% higher in Australia than pre-pandemic trends suggested, in part because of the delay in treatment.Covid continues to add to demand, too. A recent paper by the Institute for Fiscal Studies, a think-tank in London, estimates that the disease is reducing the available number of beds in the nhs by 2-7%. As covid-positive patients draw in resources, providers offer everyone worse care. Research by Thiemo Fetzer of Warwick University and Christopher Rauh of Cambridge University suggests that for every 30 or so extra covid deaths, one non-covid patient dies, “caused by the disruption to the quality of care”. The effects of malfunctioning health-care systems go beyond unnecessary deaths. People come to feel their country is falling apart. If you live in a rich country and get sick, you expect someone to help. And someone is definitely supposed to help when the tax burden is at or close to an all-time high, as it is in many places. The good news is that the backlog created by the pandemic will disappear. The surge in respiratory viruses in adults and children has probably peaked. Administrators have made progress in tackling enormous waiting lists. But with an ageing population, and covid now an ever-present threat, pre-pandemic health care may come to seem like it was from a golden age. ■ More

  • in

    Why health-care services are in chaos everywhere

    The imposition of lockdowns during the covid-19 pandemic had one overarching aim: to prevent hospitals from being overwhelmed. Governments hoped to space out infections, buying time to build capacity. In the end, however, much of this extra capacity went unused. England’s seven “Nightingale” hospitals closed having received only a few patients, as did many of America’s field hospitals. A study of Europe’s experience in Health Policy, a journal, found only one example where there were more covid patients than intensive-care beds: in the Italian region of Lombardy on April 3rd 2020. Although there are now stories of overwhelmed Chinese hospitals, as the country confronts a great exit wave, it is too soon to know whether these are isolated examples or represent broader, systematic failure.Outside China, covid weighs less on people’s minds these days. Yet health-care systems in the rich world are closer to collapse than at any point since the disease started to spread. Unlike for unemployment or gdp, there are few comparable, up-to-date figures on health care across countries. So The Economist has trawled statistics produced by countries, regions and even individual hospitals to paint a picture of what is going on. The results suggest patients, doctors and nurses did not escape the worst effects of the pandemic. Instead, the effects seem to have been delayed.Start with Britain, which produces excellent data. The National Health Service (nhs), the country’s state-run provider, is in dire straits. Just before the pandemic, someone with a medical issue requiring urgent but not immediate attention, a category that includes strokes and heart attacks, waited on average 20 minutes for an ambulance. Now they wait longer than an hour and a half (see chart). The number of long “trolley waits”—the time between a decision to admit and a patient arriving at a hospital ward—has jumped. Other countries have less comprehensive statistics, but equally miserable patients. In September Ipsos, a pollster, released a global survey that included a question on health-care quality. In almost all of the 20-odd rich countries, people were less likely than in 2021 to say that the service on offer was “good” or “very good”. In Britain the share saying so fell by five percentage points. In Canada it fell by ten. In Italy by 12.Italian hospitals inundated by covid patients in early 2020 are struggling once again. We analysed data from the Pope John XXIII hospital in Bergamo, the site of some of the harrowing images of people on ventilators nearly three years ago. In the year covid hit Italy, the hospital’s waiting lists rose slightly on some measures. They then fell slightly the next year. But in 2022 they jumped. Someone in the city looking for a non-urgent breast ultrasound may have to wait as long as two years. Officials in Emilia-Romagna, another region hit hard in 2020, have launched a plan to return waiting lists to pre-pandemic levels.Newspapers across the Anglosphere are filled with horror stories. In New South Wales, Australia, some 25% of patients had to wait more than half an hour to be transferred from paramedics to emergency-room staff in the third quarter of 2022, up from 11% two years before. In Canada waiting times have reached an all-time high, with a median delay of half a year between referral and treatment. Even the richest, most competent countries are feeling the strain. In Switzerland there are fewer free intensive-care beds than at most points in the pandemic. Germany is seeing similar problems, with a surge in patients reducing intensive-care capacity (see chart). In Singapore patients waited for about nine hours to be seen at the average polyclinic at the end of 2021. By October 2022 they were waiting for 13.America is doing better than most countries, thanks to the vast amount of money it spends on health care. But it is not doing well. Average hospital-occupancy rates recently exceeded 80% for the first time. Even in the darkest days of the pandemic few states reported paediatric wards under stress (which we define as 90% or more beds being occupied). In early November fully 17 states were in this position, the result of a rise in all sorts of bugs in kids. The collapse in the quality of health care is contributing to an astonishing rise in “excess deaths”—those above what would be expected in a normal year. In many rich-world countries 2022 proved deadlier even than 2021, a year of several big waves of covid. Monthly deaths across Europe are currently about 10% higher than expected. Germany is in the middle of a vast mortality wave: weekly deaths have been more than 10% above normal since September. In early December they were 23% higher. What is going on? Politicians, at both a national and regional level, are taking the blame—and occasionally deserve it. But the forces creating the chaos are common across countries, and are linked to a shared experience of the pandemic. They may also, in the short term at least, be almost impossible for governments to overcome. Across the oecd club of mostly rich countries, health expenditure is now not far short of 10% of gdp, having been below 9% before the pandemic (see chart). Of the 20 countries for which there are data for 2021, 18 spent more per person than ever before. Almost all spent more as a share of gdp than in 2019. Adjusting these figures for ageing populations does not meaningfully change these findings. The problems facing health-care systems are not therefore caused by a lack of cash. Much of the increased spending has gone on programmes to combat covid, including testing and tracing, and buying vaccines. But funding is now rising across systems more broadly. In almost every rich country more people are working in health care than ever before. Total employment in hospitals in 2021 was 9% higher than in the year before the pandemic in the six oecd countries we surveyed. The latest data suggest that in Canada 1.6m people now work in health care, the most ever. In the eu more than 12m people work in “human-health activities”, a record. American hospitals employ 5.3m people, another record. Perhaps the real problem is not staff numbers, but how efficiently they are working. Real output in America’s hospital and ambulatory-health-care sector, which in effect measures the quantity of care provided, is only 3.9% above its pre-pandemic level, whereas output across the economy as a whole is 6.4% higher. In England elective-care activity (ie, surgery planned in advance) is slightly lower than it was before covid hit. In Western Australia the share of delayed elective surgeries jumped from 11% to 24% in the two years to November. Hospitals are, in other words, doing less with more. Although falling productivity is an economywide phenomenon, health care currently suffers from additional pressures. A recent paper by Diane Coyle of Cambridge University and colleagues considers the effects of dealing with covid in Britain. “Donning and doffing” protocols to replace protective kit and cleaning requirements after dealing with covid patients, which are still in force in many countries today, slow everything down. The segregation of covid from non-covid patients limits bed allocation. Meanwhile, many staff feel wretched after three gruelling years. A report in Mayo Clinic Proceedings, a journal, finds that quantitative measures of “burnout” among American physicians have shot up (see chart). If health-care workers are demotivated, they may do fewer of the things that once kept the show on the road—such as staying late to make sure the patients’ register is in order or helping with the treatment of another medic’s patient. Yet even though productivity has dropped, it has not fallen by enough to fully explain the health-care collapse. This suggests that the true explanation for the breakdown lies on the other side of the coin: in exploding demand. Coming out of lockdowns, people seem to require more medical help than ever before. Some of this is to do with immunity. People went two years without being exposed to various bugs. Since then, endemic pathogens such as respiratory syncytial virus have bloomed. Everyone you know has—or has recently had—the flu. But the pandemic also bottled up other conditions, which are only now being diagnosed. In 2020-21 many people delayed seeking treatment for fear of catching covid, or because hospitals were shut to non-covid conditions. In Italy cancer diagnoses fell by 39% in 2020 compared with 2018-19. A study of American patients noted a particular reduction in diagnoses was recorded, over a similar period, in cancers normally found during a screening or routine examination. In England, the nhs waiting list has grown by more than 60% since the pandemic was declared. Many of the people on the list, and on similar ones in other countries, are likely to be sicker, and thus to take up more resources than if they had received care in 2020. A recent paper published in Lancet Public Health, another journal, estimates that over the next two decades deaths from colorectal cancer could be nearly 10% higher in Australia than pre-pandemic trends suggested, in part because of the delay in treatment.Covid continues to add to demand, too. A recent paper by the Institute for Fiscal Studies, a think-tank in London, estimates that the disease is reducing the available number of beds in the nhs by 2-7%. As covid-positive patients draw in resources, providers offer everyone worse care. Research by Thiemo Fetzer of Warwick University and Christopher Rauh of Cambridge University suggests that for every 30 or so extra covid deaths, one non-covid patient dies, “caused by the disruption to the quality of care”. The effects of malfunctioning health-care systems go beyond unnecessary deaths. People come to feel their country is falling apart. If you live in a rich country and get sick, you expect someone to help. And someone is definitely supposed to help when the tax burden is at or close to an all-time high, as it is in many places. The good news is that the backlog created by the pandemic will disappear. The surge in respiratory viruses in adults and children has probably peaked. Administrators have made progress in tackling enormous waiting lists. But with an ageing population, and covid now an ever-present threat, pre-pandemic health care may come to seem like it was from a golden age. ■ More

  • in

    FAA launches investigation after two planes nearly collide at JFK airport

    The Federal Aviation Administration has launched an investigation after two commercial airplanes narrowly avoided a collision at John F. Kennedy International Airport on Friday.
    The FAA said a Boeing 737 operated by Delta Air Lines stopped its takeoff around 8:45 p.m. when air traffic controllers noticed another American Airlines aircraft crossing the runway.
    The National Transportation Safety Board said in a tweet Sunday that it is also investigating the incident.

    Grounded Delta Airlines planes are parked at gates at John F. Kennedy International Airport on January 11, 2023, in New York.
    Yuki Iwamura | AFP | Getty Images

    The Federal Aviation Administration has launched an investigation after two commercial airplanes narrowly avoided a collision at John F. Kennedy International Airport on Friday, a spokesperson confirmed to CNBC.
    The FAA said a Boeing 737 operated by Delta Air Lines stopped its takeoff around 8:45 p.m. when air traffic controllers noticed another American Airlines aircraft crossing the runway. The Delta flight “stopped its takeoff roll approximately 1,000 feet” from the point where the American Airlines Boeing 777 had crossed, according to the FAA’s preliminary analysis.

    The agency told CNBC the information is subject to change.
    The National Transportation Safety Board said in a tweet Sunday that it is also investigating the incident.
    Flight watcher @xJonNYC noticed the near miss and shared audio of the tense air traffic control exchange on Twitter Saturday.
    “Delta 1943 cancel takeoff plans! Delta 1943 cancel takeoff plans!” one person can be heard saying.
    “Rejecting,” another person responds.

    A representative for Delta Air Lines said Flight 1943 was heading to the Dominican Republic, but after the aircraft stopped on the runway, it returned to the gate and customers deplaned.
    The flight was delayed overnight due to crew resources and departed the next morning.
    “The safety of our customers and crew is always Delta’s number one priority,” the representative said in a statement. “Delta will work with and assist aviation authorities on a full review of flight 1943 on Jan. 13 regarding a successful aborted takeoff procedure at New York-JFK. We apologize to our customers for the inconvenience and delay of their travels.”
    A spokesperson for American Airlines said the company will defer to the FAA for comment.

    WATCH LIVEWATCH IN THE APP More

  • in

    Food fraud secretly infiltrates kitchens across America — here’s how to avoid it

    The food in your kitchen cabinets may not be what it seems.
    “I guarantee you any time a product can be passed off as something more expensive, it will be. It’s that simple,” Larry Olmsted, author of “Real Food/Fake Food,” told CNBC.

    Fraudsters motivated by economic gain secretly infiltrate the global food market through a variety of means, including counterfeits, dilutions, substitution and mislabeling.
    This not only harms consumers’ wallets, but it also puts public health and safety at risk.
    Some estimates say food fraud affects at least 1% of the global food industry at a cost as high as $40 billion a year, according to the Food and Drug Administration.
    “We might not know the overall impact of food fraud because so much of what fraudsters do is hidden from us and has been for centuries.” Kristie Laurvick, senior manager of the foods program at the U.S. Pharmacopeial Convention, told CNBC.
    Even the FDA says it can’t estimate how often this fraud happens or its economic impact.

    “Be aware of products that you put in you, on you or plug in the wall,” John Spink, director of the Food Fraud Prevention Think Tank, told CNBC.
    Between 2012 and 2021, the most common type food fraud was lying about an animal’s origin and dilution or substitution, both ranking at 16% of recorded incidents by food-safety monitor Food Chain ID.
    For example, dilution could entail adding a cheaper vegetable oil to an expensive extra virgin olive oil.
    “If I drink scotch, I couldn’t tell you [the] difference between a $50 bottle and a $5,000 bottle. So, I know I could be deceived at that point,” Spink said.
    The Food Fraud Prevention Think Tank suggests five questions a consumer can ask themselves to reduce their vulnerability to product fraud.

    What type of product is it? Take extra caution with any product that you put on your body, ingest or plug in the wall.
    Can you recognize the difference between products?
    Do you know the retailer or supplier? Do you trust them?
    Are you shopping online? If so, did you find the online supplier from a reliable source?
    Complain. Is the supplier legitimate? If so, they will want to know.

    Watch the video above to learn more about the different types of food fraud, how the industry is preventing risk, what consumers can do and where fraud in the olive oil, spices and seafood markets may be lurking.

    WATCH LIVEWATCH IN THE APP More

  • in

    10 auto industry predictions for investors to keep an eye on this year

    Wall Street and industry analysts remain on high alert for signs of a “demand destruction” scenario for the U.S. automotive industry this year.
    Cox Automotive’s 10 predictions for the U.S. auto industry point to a challenging year ahead.
    They range from electric vehicle sales outpacing the overall industry to concerns about consumer demand amid economic pressures.

    A customer looks at a vehicle at a BMW dealership in Mountain View, California, on Dec. 14, 2022.
    David Paul Morris | Bloomberg | Getty Images

    DETROIT — Wall Street and industry analysts remain on high alert for signs of a “demand destruction” scenario for the U.S. automotive industry this year as interest rates rise and consumers grapple with vehicle-affordability issues and fears of a recession.
    Since the onset of the coronavirus pandemic in early 2020, automakers have experienced unprecedented pricing power and profits per vehicle amid resilient demand and low inventory levels due to supply chain and parts disruptions affecting vehicle production.

    Those factors created a supply problem for the auto industry, which Cox Automotive and others believe may switch to a demand problem — just as automakers are slowly improving production.
    “We’re swapping a supply problem for a demand problem,” Cox Automotive chief economist Jonathan Smoke said Thursday.
    Cox has 10 predictions for the U.S. auto industry this year that point to such an outcome. Here they are along with reasons why investors should be mindful of them.

    10. Federal incentives will encourage more fleet buyers to consider electrified solutions

    While electric vehicle tax credits under the Inflation Reduction Act have not been finalized, incentives for commercial vehicles and fleet owners promise to be a major benefit.
    Unlike consumer vehicles that qualify for credits of up to $7,500, fleet and commercial vehicles do not need to meet stringent U.S. requirements for domestic parts and batteries.  

    “This is actually where we think the majority of growth will be in new vehicle sales in ’23,” Smoke said.
    Cox forecasts U.S. new vehicle sales will be 14.1 million in 2023, a slight increase from nearly 13.9 million last year.

    9. Half of vehicle buyers will engage with digital retailing tools

    The coronavirus pandemic forced franchise auto dealers to embrace online retailing more than automakers ever could, as consumers demanded it and many physical dealerships were shuttered due to the global health crisis.
    That trend is expected to continue for years to come, as many automakers have vowed to better align production with consumer demand.

    8. Dealership-service operations volume and revenue climb

    Due to a lack of available new vehicles and higher costs, consumers are keeping their vehicles longer. This is expected to increase back-end service business and revenue for dealers compared to their sales. Dealers make notable profits from servicing vehicles. The increase is expected to assist in offsetting potential declines in sales and financing options.
    “We see this as one of the silver linings for dealers,” Smoke said. “The service department usually does well [and] is somewhat counter-cyclical during economic downturns.”

    7. All-cash deals will increase to levels not seen in decades

    High interest rates are making vehicle purchasing far more challenging for mainstream buyers and less economical for more wealthy consumers. Such conditions are expected to push those who have the cash to purchase a vehicle to buy it without financing it.
    Smoke said the average loan rate for a new vehicle is more than 8%. For used vehicles, it’s close to 13%.

    6. Vehicle affordability will be the greatest challenge facing buyers

    Vehicle affordability was already a concern when interest rates were low. This issue has grown to be more concerning as the Federal Reserve pumps up interest rates to battle inflation. Cox reports vehicle affordability is at record lows.
    The increases have led to upticks in average monthly payments of $785 for new cars and $661 for leases, Cox said. The average list price of a new vehicle remains above $27,000, while average transaction prices for new vehicles ended last year at about $49,500.
    “The longer-term concern is that this causes what is produced to skew even more towards luxury and away from affordable price points, which means even the U.S. vehicle market has a long-term affordability issue,” Smoke said.

    5. Used-vehicle values will see above normal depreciation for a second straight year

    Used vehicle prices skyrocketed during the first two years of the coronavirus pandemic due to the low availability of new cars and trucks. The wholesale pricing peaked in January 2022. It declined 14.9% last year and is expected to fall another 4.3% by year-end.
    The declines are still not enough to offset the 88% rise in index pricing from April 2020 to January 2022.
    Inventory of used vehicles is stabilizing at nearly 50 days — close to 2019 levels before the coronavirus pandemic depleted supply.

    4. Sales of electric vehicles in the U.S. will surpass 1 million units for the first time

    Cox reports all-electric vehicle sales increased by 66% to more than 808,000 units last year in the U.S., so it’s not too much of a leap to hit 1 million amid dozens of new models scheduled to hit the market. EVs represented about 5.8% of new vehicles sold in the U.S.
    Add in hybrid and plug-in hybrid electric vehicles that pair with a traditional engine, Smoke said about 25% of new vehicles sold this year to be “electrified” vehicles. That would be up from 15% to 16% in 2022.

    3. Total retail vehicle sales will fall in 2023, as new vehicle sales grow, used sales decline

    Automakers are expected to rely more heavily on sales to commercial and fleet customers such as rental car and government agencies than they have in recent years to increase total sales.
    Carmakers prioritized the more profitable sales to consumers amid the low inventories in recent years. But with consumer demand anticipated to fall, companies are expected to turn to fleet sales to fill that demand gap.

    2. New vehicle inventory levels will continue to increase

    Expectations for lower demand come as the automotive industry is slowly increasing its production of vehicles, leading to higher inventory levels.
    Inventory levels the past two years were at record lows due to supply chain and parts problems affecting production.
    Cox reports inventory levels greatly differ based by brand, with the Detroit automakers — specifically Stellantis — having an ample supply of vehicles. Toyota has the lowest days of supply of vehicles, according to Cox.

    1. A slow-growing economy will place pressure on the automotive market

    Combine all of the prior predictions in addition to the economic concerns and that’s a lot of pressure on the U.S. automotive industry in the year ahead.
    This is also happening during a time when automakers are investing billions in electric vehicles and new technologies such as advanced driver-assistance systems and autonomous vehicles.
    “We hope for an economic soft landing but ether way we believe the auto market is going to be held back in the year ahead,” Smoke said.

    WATCH LIVEWATCH IN THE APP More

  • in

    Tesla and the EV industry get their first recession stress test. Will it be a bust?

    Auto companies are among the most sensitive to higher interest rates and a weaker consumer.
    The EV industry also has aspects of high-growth tech — the dot-com bust, and later boom, suggests the strong will survive a winnowing-out. 
    Tesla is flush with cash and may generate $4 billion more this quarter.
    Competitors like Rivian, Fisker and Lucid are the “middle tier” of the new industry.
    One investor whose has recently made money shorting the sector tells CNBC, “Those with the capital to get through 2023, we’d bet the farm on.”

    Pedestrians walk past the Tesla Motors official authorized car dealer store in Hong Kong.
    Sopa Images | Lightrocket | Getty Images

    Is the first electric-vehicle recession here, or coming soon?
    As electric-car stocks plummeted in late 2022, the rout evoked comparisons to the dot-com stock bust two decades ago. Like the internet industry then, the EV industry boasts companies, notably Tesla,  that look like long-term winners, but it is also made up of young companies that may not have the cash to ride out a downturn, as well as in-between players like Lucid Group, Fisker and Rivian Automotive, that have done their best to prepare, and whose fate may depend on how bad things get.

    With the economy at an inflection point between receding inflation fears and broad expectation of a recession beginning in 2023, the market doesn’t know what to make of moves like Tesla’s big price cuts, first in China and then on Jan. 13, in the U.S. and Europe. Analysts like Guggenheim Securities’ Ronald Jesikow said it could push Tesla’s profit margins 25% lower than Wall Street consensus and drain profits from all of Tesla’s competitors. But optimists like Wedbush analyst Dan Ives think it’s the right, aggressive move to jumpstart the EV transition amid macro uncertainty.
    “Many dot-coms didn’t make it,” Ives said. “There’s no stress test for a severe recession for an industry that’s in its infancy.” 
    What happens next — whether battered EV stocks rebound, whether young companies that need more funding will be able to get it, and whether the sector becomes the jobs engine Washington was counting on when it passed the Inflation Reduction Act last summer, laden with tax credits for EVs — depends on the economy first, and the markets second.
    The “first EV recession” theme comes with a big if – that there is a recession in the first place, either here or in China, where Tesla sales dropped 44 percent in December from November levels as the government there continued struggling to contain Covid-19. 
    In the U.S., most economists and CEOs think a recession is likely this year, though the market gains of the last week may reflect the beginnings of a change in the investor outlook, with more believing in the “soft landing” narrative for the economy. One holdout, Moody’s Analytics chief economist Mark Zandi, forecasts a months-long “slowcession” where growth doesn’t quite turn negative. Either scenario would likely hurt car sales in general, which were the worst in a decade in the U.S. last year, but where some auto executives are now slightly more confident about a rebound, though the EV outlook among the automakers has become more cautious in the short-term. But either scenario may be too pessimistic if the economy responds positively to now-slowing inflation.

    The outlook from China, home to more than half of the world’s EV sales, according to Clean Technica, is at least as murky. Manufacturing moved into negative-growth territory late in the year and housing prices are falling, but the International Monetary Fund says China will avoid a recession and grow its economy by 3.8% this year. That would be half of 2021’s clip and slightly below China’s pace last summer, when the nation began to cope with new Covid-related shutdowns. China is now pushing to reopen its economy amid the pandemic. 
    Tesla’s 2023 world is like Amazon and eBay’s 2000
    A recession, if it happens, doesn’t necessarily mean EV sales will fall. Most models saw big sales gains last year in both the U.S. and Asia. It’s more a question of whether EV companies will grow fast enough to keep adding jobs, and for companies beyond Tesla to turn profitable when investors expect them to — or before they run out of cash they raised to fund startup losses.
    That sets up a dynamic a lot like the one that confronted dot-com companies like Amazon and eBay as 2000 blended into 2001: A web-stock selloff was well-underway then, just as EV companies like Tesla, Fisker and Lucid fell sharply last year — 65 percent for Tesla, 54 percent for Fisker and 82 percent for Lucid. Then as now, weaker players like today’s EV makers Lordstown Motors, Faraday Future and Canoo were scrambling to avoid running out of cash as an economic slowdown loomed, either by cutting costs or raising more money from investors.
    “We look at a combination of balance sheet stability and ability to raise more capital,” said Greg Bissuk, CEO of AXS Investments in New York, which runs an exchange-traded fund that uses swaps to deliver the opposite of Tesla’s daily return — in essence, usually a near-term bet that the shares will drop. “We think it will be rocky,” he said, specifically referring to the middle-tier EV makers.
    But at the same time, revenue at dot-com companies kept rising fast, and the businesses that were  destined to survive began to turn profitable between 2001 and 2003. Today, EV sales in China are rising, even as Covid continues to hamper its economy, and EVs posted a 52% sales gain in the U.S. At year-end, EVs had 6% of the U.S. light-vehicle market, compared to 1 percent of U.S. retail sales being online in late 2000.
    Slower growth isn’t no growth
    For EV makers, the likely impact of a recession is slower growth, but not the negative growth the overall economy experiences in a downturn, as new technology keeps gaining market share. 
    The best-positioned EV maker is still Tesla, said CFRA Research analyst Garrett Nelson. With the company still expected to have generated about $4 billion in late-2022 cash flow when it reports fourth-quarter earnings Jan. 25, and having had about $21 billion at the end of the third quarter, it’s not in danger of a cash burn, Ives said.
    “We think the stock rebounds quickly this year,” Nelson said, calling Tesla his top pick among all auto makers, and noting that CFRA economists don’t expect a recession. It trades at 24 times this year’s profit estimates, which in turn only call for 25% profit growth, numbers that are modest for a growth company with room to keep expanding fast.

    After the price cut, Nelson said the company will see narrower profit margin but will sell more cars.
    “It should widen the company’s competitive advantage and make many more Tesla vehicles eligible for the $7,500 federal EV tax credit,” Nelson said.
    The just-enacted price cut pulled the most-popular Model Y vehicles under the price maximum for tax-credit eligibility in the 2022 Inflation Reduction Act.
    Tesla has its own issues, with sales growth having slowed late in the year. Fourth-quarter units were up 32%, down sharply from earlier in the year, missing Wall Street estimates for a second straight quarter. CEO Elon Musk’s antics as the new lead owner of Twitter raise concerns about how closely Musk is watching the store, and how quickly he may respond if Tesla’s decline accelerates, Ives said.
    “The biggest [issue] is Twitter,” Nelson said. 
    On the plus side, this year’s earnings estimates assume no contribution from the Cybertruck, which Tesla is again promising to launch late this year, after being delayed since 2021. And Goldman Sachs analyst Mark Delaney wrote Jan. 2 that vehicle deliveries should reaccelerate by midyear, helped by lower cost structures at Tesla’s newer factories and a pickup in Chinese sales.  
    “Now is a time for leadership from Musk to lead Tesla through this period of softer demand in a darker macro, and not the time to be hands off, which is the perception of the Street,” Ives said. “This is a fork-in-the-road year for Tesla, where it will either lay the groundwork for its next chapter of growth or continue its slide.”
    Cash burn and the rest of the EV market
    In the middle, Lucid, Rivian and Fisker make up a range of higher-risk possibilities that may well turn out fine in the end. But Tesla’s price cutting may cause them problems: Fisker’s stock dropped almost 10% on its rival’s announcement, since Tesla’s move puts the Model Y’s price closer to that of the Fisker Ocean, whose middle tier is around $50,000.
    Of the three, Rivian has the most cash on hand, with short-term investments at $13.3 billion as of the end of the third quarter. Fisker had $829 million, and Lucid had $3.85 billion.
    Each company is still burning cash, posing the question of whether they have enough to survive a downturn. Fisker lost about $480 million in cash flow in the 12 months ending in September, and invested another $220 million, meaning its cash would last between one and two years if its losses and investment didn’t slow.
    “Our commitment to a lean business model has given us a solid balance sheet, which we have supported with disciplined management of our cash,” CEO Henrik Fisker said in a statement to CNBC. “We are in good shape to manage future economic challenges and to act on opportunities.”
    Lucid spent over $2 billion in the first nine months of 2022 on operating cash flow losses and capital investment, and says its cash will cover its plans “at least into the fourth quarter of 2023,” according to its third-quarter earnings call. Lucid’s recent production and delivery numbers did beat expectations, albeit expectations that had already been lowered.
    Rivian’s stockpile is more than two years’ worth of recent cash-flow losses and investment. 
    All three companies, which declined or didn’t respond to on-the-record interview requests, can also extend their cash runway by raising more capital and, indeed, at least two of them have already begun to do so. Lucid raised another $1.515 billion in December, mostly from Saudi Arabia’s Public Investment Fund, while Fisker has filed to raise $2 billion from an ongoing shelf registration at the Securities and Exchange Commission and has so far raised $116 million.

    All three should also give financial guidance for 2023 during earnings season, including updates on their capital spending, and on whether cash-flow losses will narrow as they begin to ship more vehicles.
    Fisker began shipping its initial model, the Fisker Ocean, only in mid-November, and plans to ship a less-expensive SUV called the Fisker PEAR next year. Rivian, hampered by parts shortages due to Covid-driven supply chain issues, missed its 2022 production target of 25,000 vehicles by less than 700. It hasn’t yet said how many cars it will ship this year. Rivian also paused a partnership with Mercedes in November, ending for now a plan to co-develop commercial vehicles. Rivian said it would concentrate on its consumer business and other commercial ventures, primarily a deal to sell delivery vans to Amazon, that offer better risk-adjusted returns. That move will help avoid pressure on the startup’s capital base.
    Business plans for the future, little current business
    Lower on the food chain are companies like Faraday Future Intelligent Electric, Canoo and Lordstown Motors, which went public via mergers with Special Purpose Acquisition Companies, or SPACs, and have lost most of their equity value since. 
    Lordstown in November announced a fresh investment by Foxconn, the contract manufacturer that will own 19.9% of Lordstown after the deal, including preferred stock, to help scale up production of its initial pickup truck and bolster the $204 million in cash on its balance sheet. Foxconn has agreed to make Fisker vehicles in Lordstown’s Ohio factory, which Foxconn bought in May, for launch in 2024. It issued a going-concern warning in 2021, before raising money from Foxconn.
    “The new capital from Foxconn doesn’t change our focus” on cost containment, Lordstown CFO Adam Kroll said, arguing that the Foxconn deal will slash Lordstown’s capital needs. “We continue to execute a playbook of prudence and discipline.”
    Companies like Faraday, Canoo and Lordstown that need to raise more capital could find the path blocked by a more-skeptical capital market than the one that financed them during the special-purpose acquisition company boom, CFRA’s Nelson said. Weaker players include Electro Mechanica, which has proposed a solo EV but hasn’t shipped it in scale yet, British commercial-vehicle maker Arrival, and Green Power Motor, a Canadian electric bus maker, he said. He even includes Fisker, Lucid and Rivian among those at risk from tighter markets.
    “They had a business plan but no business, and they got absurd amounts of capital,” Nelson said. “In our opinion, you’ll see many additional bankruptcies, but the market will return to balance. But it’s hard to imagine we’ve seen the bottom.” 
    But Nelson does believe the electric car boom is for real — indeed, he says Tesla is the year’s best bet in the overall auto industry. A note of skepticism: After the dot-com boom and bust, Amazon.com began rising off its lows in 2002, rising tenfold by 2008, but didn’t leave its 1999 highs behind for good until 2010. EBay recovered faster but couldn’t sustain its momentum. 
    Ives said the Inflation Reduction Act, which offers tax credits of  $7,500 for electric cars costing less than $55,000 and SUVs or pickups selling for $80,000 or less, may throw the industry a lifeline as companies arrange to do enough domestic manufacturing to qualify all of their vehicles. Arrival, citing IRA credits of up to $40,000 for buyers of commercial vehicles, said in November that it is refocusing its London-based company on the U.S. market.
    “The pressure in 2023 is less about EVs than the overall macro environment,” Ives said.  “The IRA is not a small point.”
    That’s not lost even on Bassuk, who emphasizes that his fund is about helping exploit short-term weakness in the market’s view of EVs. Long-term, he says, EVs are coming, recession or not.
    “Those with the capital to get through 2023, we’d bet the farm on,” he said.

    CNBC is now accepting nominations for the 2023 Disruptor 50 list – our 11th annual look at the most innovative venture-backed companies. Learn more about eligibility and how to submit an application by Friday, Feb. 17. More

  • in

    Are you buying ‘too much car’? Americans’ obsession with pricey options like touch screens is causing an affordability crisis

    Over the last decade, car shoppers have proved their willingness to spend more on high-end cars with all the options.
    With the lucrative luxury segment in such high demand, carmakers continue to upgrade their lineups and scale back on less expensive cars.

    If you haven’t shopped for a car lately, brace for sticker shock.
    Not only are vehicle prices at an all-time high, but the interest rate to finance a purchase has also jumped dramatically. A record 15% of new car buyers who financed a new car last quarter committed to a monthly payment of more than $1,000, according to Edmunds. 

    Such a tall tab can lead to affordability problems down the road, cautioned Ivan Drury, Edmunds’ director of insights. Shelling out more to buy a car today puts consumers at greater risk of going underwater on those loans later on as used car values decline, he said.
    More from Personal Finance:Interest rate hikes have made financing a car pricier10 cars with the greatest potential lifespanCar deals are hard to come by
    With that in mind, Drury cautions car shoppers to ask themselves if they’re “buying too much car.”

    ‘Every new car is a luxury purchase’

    Part of the problem is that more Americans want expensive SUVs and pickups with all the options, he added, which can cost as much as 40% more than the base price.
    Over the last decade, luxury shoppers have proved again and again their willingness to spend more on high-end cars and the financing to go along with them.

    Even the smallest upgrades have been met with soaring demand, Drury said, citing the extreme enthusiasm over the Honda Odyssey’s built-in vacuum option when it was first introduced in 2014.
    Various packages, or trim levels, offer a range of features meant to appeal to different buyers, such as improved safety features, bigger engines or high-end finishes like leather seats and a better stereo.
    Now everyone wants high-tech touch screens, ambient lighting, 360-degree cameras and heated and cooled seats, Drury said, which cost even more. “Less and less people want something basic.”
    With the lucrative luxury segment in high demand, carmakers are upgrading their lineups and scaling back on less expensive cars.

    “Base models, while enticing in theory, rarely hit the street,” Drury said. “Every new car is a luxury purchase at this point.”
    “Who do you blame: The consumer that’s buying up these options, the dealers that are ordering these cars or automakers manufacturing fewer base models?” he said.
    As more people are priced out of the new car market, automakers may start testing out cheaper alternatives, he said, although if there is a lot of consumer interest, it could drive up the price for those models, as well.
    For now, the best way to get a base model vehicle is to order it directly through a dealer, Drury advised.
    “There could be a perfectly good substitute at about half the cost,” he said.
    Subscribe to CNBC on YouTube.

    WATCH LIVEWATCH IN THE APP More